Nuclear Medicine Department
The department of Nuclear Medicine has a routine PET CT Scan and a Low-Dose Therapy ward, where 177-Lu PSMA therapy is available for hormone-resistant prostate cancer.
The department of Nuclear Medicine has a routine PET CT Scan and a Low-Dose Therapy ward, where 177-Lu PSMA therapy is available for hormone-resistant prostate cancer.
A specialist-helmed multi-disciplinary tumour board has been set up to ensure that all patients get the best treatment plan at MTMH.
Pathology provides immunohistochemistry as an advanced test, besides histopathology, cytology, tumour markers, drug levels like Methotrexate and routine tests. Real-time PCR-based EGFR panel, HRHPV on FFPE, BCR ABL with IS% on Peripheral and bone marrow samples are also carried out.